Hot Life Science Investor Mandate 2: PE Group with Diverse Investment Interests Seeking New Targets – April 4, 2013

1 Apr

A private equity group based in the Central US has raised three funds, and has around $300 million in total assets under management. The firm is always looking for new opportunities in the life science space, and typically allocates around $20 million per firm ($10 million of the group’s allocation is typically equity, the remainder is financed using debt).
 
The firm is currently most interested in companies within the suppliers and engineering space, as well as biotech R&D service companies. The firm is particularly looking for medical device companies, as well as CMOs and niche chemical production companies. The firm solely invests in US based firms.
 
The PEG is only looking for firms that currently have products that are on the market. Additionally, they are looking for companies that have at least $15-100 million in annualrevenue, and prefer firms with annual EBITDA in the $3-15 million range. Consequently, the firm will not consider early stage pre-revenue companies.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: